WCM
SZYM

Wealthcare Capital Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Wealthcare Capital Management’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,200
Closed -$8K – 273
2015
Q3 		$8K Hold
3,200
– – ﹤0.01% 173
2015
Q2 		$10K Buy
+3,200
New +$11K ﹤0.01% 211

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wealthcare Capital Management's SZYM Position: Q4 2015 in Review

Wealthcare Capital Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2015, closing a stake of 3,200 shares — an estimated $8K sold.

Wealthcare Capital Management first reported a position in SZYM in Q2 2015 and held it in 2 quarters. The position peaked at $10K in Q2 2015. 108 funds tracked by Wall St. Rank hold SZYM as of Q4 2015.

  • Wealthcare Capital Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Wealthcare Capital Management sold 3,200 SOLAZYME INC COM STK (DE) shares in Q4 2015, an estimated $8K.
  • Wealthcare Capital Management first reported a position in SOLAZYME INC COM STK (DE) in Q2 2015 and held it in 2 quarters.
  • Wealthcare Capital Management's SOLAZYME INC COM STK (DE) position peaked at $10K in Q2 2015.
  • 108 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2015.

Based on Wealthcare Capital Management's 13F filing for Q4 2015, filed 13 Jan 2016.